1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 study of zenocutuzumab (MCLA-128), a bispecific HER2/HER3 antibody in NRG1 fusion-positive advanced solid tumors
    Meeting Abstract

    Schram, A.; Macarulla, T.; O'Reilly, E.; Rodon, J.; Wolpin, B.; Ou, S.; Kim, D.; Yang, J. C.; Lam, J.; De Langen, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Activity of tepotinib in brain metastases (BM): Preclinical and clinical data in MET exon 14 (METex14) skipping NSCLC
    Meeting Abstract

    Mazieres, J.; Veillon, R.; Felip, E.; Le, X.; Garassino, M. C.; Stanton, T.; Morise, M.; Lee, J.; Matsumoto, S.; De Marinis, F.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • A phase 2 study of erdafitinib in patients with advanced solid tumors and fibroblast growth factor receptor gene alterations
    Meeting Abstract

    Pant, S.; Tabernero, J.; Massard, C.; Hyman, D. M.; Witt, O.; Doi, T.; Qin, S.; Lu-Emerson, C.; Hargrave, D.; Garcia-Corbacho, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Delta-radiomics features for assessment of individualized therapeutic response in small cell lung cancer - A pilot study
    Meeting Abstract

    Araujo Filho, J.; Murciano-Goroff, Y.; Gibbs, P.; Perez-Johnston, R.; Lai, W. V.; Rudin, C.; Li, B.; Ginsberg, M.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • ORCHARD: A biomarker-directed phase 2 platform study in pts with advanced EGFRm NSCLC progressing on first-line osimertinib
    Meeting Abstract

    Cho, B. C.; Piotrowska, Z.; Le, X.; Goldberg, S. B.; Goldman, J.; De Langen, A.; Okamoto, I.; Smith, P.; Mensi, I.; Maidment, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • CD8α-enhanced NY-ESO-1-specific TCR T Cells (GSK3901961) in HLA-A*02 patients with NSCLC: Master protocol substudy 1
    Meeting Abstract

    Altan, M.; Govindan, R.; Schoenfeld, A.; Noujaim, J.; Sacher, A.; Haanen, J.; Huang, C.; Hasan, A.; Faitg, T.; Butler, E.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Diminished efficacy of PD-(L)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status
    Meeting Abstract

    Ricciuti, B.; Arbour, K.; Lin, J.; Vajdi, A.; Tolstorukov, M.; Hong, L.; Zhang, J.; Vokes, N.; Li, Y.; Spurr, L.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • MERMAID-1: A phase III study of adjuvant durvalumab plus chemotherapy in resected NSCLC patients with MRD+ post-surgery
    Meeting Abstract

    Peters, S.; Spigel, D.; Ahn, M.; Tsuboi, M.; Chaft, J.; Harpole, D.; Goss, G.; Barlesi, F.; Abbosh, C.; Poole, L.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Replication of overall survival in chemotherapy arms of 1L NSCLC trials using real-world data external controls
    Meeting Abstract

    Pal, N.; Ton, T.; Trinh, H.; Bretscher, M.; Machado, R.; Mahrus, S.; Riely, G.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Using patient-level data from electronic health records to replicate PFS outcomes for four 1L NSCLC trials
    Meeting Abstract

    Bretscher, M.; Machado, R.; Ton, T.; Pal, N.; Trinh, H.; Mahrus, S.; Riely, G.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save